Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease by Gilat, Moran et al.
Author’s Accepted Manuscript
Dopamine depletion impairs gait automaticity by
altering cortico-striatal and cerebellar processing in
Parkinson's disease
Moran Gilat, Peter T. Bell, Kaylena A. Ehgoetz
Martens, Matthew J. Georgiades, Julie M. Hall,
Courtney C. Walton, Simon J.G. Lewis, James M.
Shine
PII: S1053-8119(17)30184-2
DOI: http://dx.doi.org/10.1016/j.neuroimage.2017.02.073
Reference: YNIMG13858
To appear in: NeuroImage
Received date: 27 November 2016
Revised date: 22 February 2017
Accepted date: 24 February 2017
Cite this article as: Moran Gilat, Peter T. Bell, Kaylena A. Ehgoetz Martens,
Matthew J. Georgiades, Julie M. Hall, Courtney C. Walton, Simon J.G. Lewis
and James M. Shine, Dopamine depletion impairs gait automaticity by altering
cortico-striatal and cerebellar processing in Parkinson's disease, NeuroImage,
http://dx.doi.org/10.1016/j.neuroimage.2017.02.073
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
www.elsevier.com
 1 
Dopamine depletion impairs gait automaticity by altering cortico-striatal and 
cerebellar processing in Parkinson’s disease 
 
Moran Gilat
a*
, Peter T. Bell
b
, Kaylena A. Ehgoetz Martens
a
, Matthew J. Georgiades
a
, 
Julie M. Hall
a
, Courtney C. Walton
a
, Simon J.G. Lewis
a1
, James M. Shine
c,d1
 
 
a
Parkinson’s Disease Research Clinic, Brain and Mind Centre, The University of 
Sydney, Sydney, NSW, Australia 
b
University of Queensland Centre for Clinical Research, University of Queensland, 
Brisbane, QLD, Australia 
c
Department of Psychology, Stanford University, Stanford, CA, United States of 
America 
d
Neuroscience Research Australia, Neuroscience Research Australia, University of 
New South Wales, Sydney, NSW, Australia 
 
*
Corresponding Author, Moran Gilat, 100 Mallett Street, Camperdown, 2050, 
NSW, Australia, moran.gilat@sydney.edu.au 
 
Abstract 
Impairments in motor automaticity cause patients with Parkinson’s disease to rely on 
attentional resources during gait, resulting in greater motor variability and a higher 
risk of falls. Although dopaminergic circuitry is known to play an important role in 
motor automaticity, little evidence exists on the neural mechanisms underlying the 
breakdown of locomotor automaticity in Parkinson’s disease. This impedes clinical 
management and is in great part due to mobility restrictions that accompany the 
neuroimaging of gait. This study therefore utilized a virtual reality gait paradigm in 
conjunction with functional MRI to investigate the role of dopaminergic medication 
on lower limb motor automaticity in 23 patients with Parkinson’s disease that were 
measured both on and off dopaminergic medication. Participants either operated foot 
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pedals to navigate a corridor (‘walk’ condition) or watched the screen while a 
researcher operated the paradigm from outside the scanner (‘watch’ condition), a 
setting that controlled for the non-motor aspects of the task. Step time variability 
during walk was used as a surrogate measure for motor automaticity (where higher 
variability equates to reduced automaticity), and patients demonstrated a predicted 
increase in step time variability during the dopaminergic “off” state. During the “off” 
state, subjects showed an increased blood oxygen level-dependent response in the 
bilateral orbitofrontal cortices (walk>watch). To estimate step time variability, a 
parametric modulator was designed that allowed for the examination of brain regions 
associated with periods of decreased automaticity. This analysis showed that patients 
on dopaminergic medication recruited the cerebellum during periods of increasing 
variability, whereas patients off medication instead relied upon cortical regions 
implicated in cognitive control. Finally, a task-based functional connectivity analysis 
was conducted to examine the manner in which dopamine modulates large-scale 
network interactions during gait. A main effect of medication was found for 
functional connectivity within an attentional motor network and a significant 
condition by medication interaction for functional connectivity was found within the 
striatum. Furthermore, functional connectivity within the striatum correlated strongly 
with increasing step time variability during walk in the off state (r=0.616, p=0.002), 
but not in the on state (r=-0.233, p=0.284). Post-hoc analyses revealed that functional 
connectivity in the dopamine depleted state within an orbitofrontal-striatal limbic 
circuit was correlated with worse step time variability (r=0.653, p<0.001). Overall, 
this study demonstrates that dopamine ameliorates gait automaticity in Parkinson’s 
disease by altering striatal, limbic and cerebellar processing, thereby informing future 
therapeutic avenues for gait and falls prevention. 
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Introduction  
 
Impairments in motor automaticity are a hallmark feature of Parkinson’s disease that 
cause patients to increasingly demand cortical resources in order to execute basic 
motor operations via attentional processes (Bohnen and Jahn, 2013; Wu et al., 2015). 
A reduction in motor automaticity is of particular concern during gait in Parkinson’s 
disease, as the cortical resources that would be used for compensation are not 
optimized for the fast and parallel processing required during locomotion (Clark, 
2015). Furthermore, the excessive attentional demand of walking in Parkinson’s 
disease demands a high computational cost and interferes with gait control in 
conditions of high workload (Schneider and Chein, 2003; Lewis and Barker, 2009; 
Lewis and Shine, 2014; Clark, 2015; Wu et al., 2015). As a result, patients with 
Parkinson’s disease have a greater risk of adverse mobility outcomes and falls, 
especially during more complex everyday situations where a secondary task is 
performed in parallel with gait (Schaafsma et al., 2003; Clark, 2015; Hausdorff, et al., 
2003a; Vandenbossche et al., 2012; Lewis and Shine, 2014; Strouwen et al., 2015; 
Wu et al., 2015). Despite the clinical importance of gait in Parkinson’s disease, the 
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precise neural mechanisms underlying impairments in locomotor automaticity remain 
poorly understood, thus impeding targeted management (Wu et al., 2015). 
 
Increased step time variability is a robust predictor for falls in Parkinson’s disease 
(Hausdorff et al., 1998) and has previously been suggested as a surrogate measure for 
reduced locomotor automaticity (Frenkel-Toledo et al., 2005; Yogev et al., 2005; 
Peterson and Horak, 2016). A recently proposed framework by Wu and colleagues 
(2015) outlines several features that indicate whether a motor deficit is directly linked 
to an underlying impairment in motor automaticity in Parkinson’s disease, namely: i) 
the motor skill is performed automatically (and without behavioural interference) in 
healthy subjects; ii) dual task performance results in significant deterioration in the 
motor skill in patients with Parkinson’s disease as compared to healthy subjects; and 
iii) external cueing (or attention) significantly improves the performance of this motor 
skill (Wu et al., 2015). If this theoretical model is applied to the existing literature, it 
indeed becomes evident that step time variability fits these criteria as an index of 
locomotor automaticity: i) stride time variability is resistant to interference during 
dual-task walking in healthy subjects (Yogev et al., 2005), suggesting that regulation 
of stride time variability is an automated motor skill in healthy subjects (Friedman et 
al., 1982; Yogev et al., 2005; Wu et al., 2015); ii) in Parkinson’s disease, walking 
while performing a cognitive dual task exacerbates stride time variability (Hausdorff, 
et al., 2003b; Yogev et al., 2005; Plotnik et al., 2011) and patients experience higher 
dual task cost during walking as compared to healthy subjects (Yogev et al., 2005); 
iii) stride time variability in Parkinson’s disease has been shown to reduce in the 
presence of external auditory cues (Willems et al., 2006; Hausdorff et al., 2007; 
Rochester et al., 2011). Therefore, this evidence suggests that step time variability, 
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the regulation of which is an automated process in the healthy population, is impaired 
in Parkinson’s disease and reflective of reduced motor automaticity (Yogev et al., 
2005; Bohnen and Jahn, 2013; Lewis and Shine, 2014; Wu et al., 2015; Peterson and 
Horak, 2016).  
 
 
Motor automaticity is typically achieved through motor learning, followed by the 
timely initiation and maintenance of automated motor sequences, even during 
interference (Wu et al., 2015). During motor learning, the posterior striatum 
(putamen) is thought to ‘chunk’ motor action sequences under the influence of 
dopamine (Graybiel, 1998). This process allows performance of well-learned motor 
patterns to be executed as a single unit of activity rather than multiple serial 
computations, enhancing neural efficiency and reducing motor variability (Schneider 
and Chein, 2003; Poldrack et al., 2005; Wymbs et al., 2012; Wu et al., 2015). The 
initiation of an automatic sequence is thought to involve a shift from the anterior 
associative fronto-striatal circuit to the posterior sensorimotor striatum (Miyachi et 
al., 1997; Lehéricy et al., 2005; Wymbs et al., 2012; Wu et al., 2015), which frees up 
frontal attentional resources that can then be used to process concurrent secondary 
demands (Carbon and Marié, 2003; Monchi et al., 2007; Lewis and Shine, 2014; Wu 
et al., 2015). The most well described circuits involved with maintaining an 
automated motor sequence include the spinal cord, brainstem locomotor regions, 
posterior striatum, primary cortical motor regions and cerebellum (Figure 1) 
(Poldrack et al., 2005; Bohnen and Jahn, 2013; Clark, 2015; Wu et al., 2015). Doyon 
et al. (2002) further proposed that during motor learning, a transfer of experience-
dependent changes from the cerebellar cortex to the deep cerebellar dentate nucleus 
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takes place, and then with extended practice, from a cerebellar-cortical to a striatal-
cortical network (Doyon et al., 2002). Evidently, a well functioning striatum is 
integral for effective locomotor automaticity (Wu et al., 2015). 
 
Ascending dopaminergic neurons in the midbrain provide rich innervation to the 
entire striatum, thereby exerting neuromodulatory control over information processing 
across the striatum and parallel cortico-striatal loops that underpin the execution of 
coordinated behaviours (Alexander et al., 1986; Kelly et al., 2009; Helmich et al., 
2010; Surmeier et al., 2010; Hacker et al., 2012; Sharman et al., 2013; Bell et al., 
2014). In Parkinson’s disease, the pathological degeneration of nigrostriatal 
dopaminergic neurons impacts on the communication across the striatum and parallel 
cortico-striatal circuits (Alexander et al., 1986; Kelly et al., 2009; Helmich et al., 
2010; Surmeier et al., 2010; Hacker et al., 2012; Sharman et al., 2013; Bell et al., 
2014), which likely impairs motor learning and automaticity (Figure 1) 
(Vandenbossche et al., 2012; Bohnen and Jahn, 2013; Lewis and Shine, 2014; 
Hamacher et al., 2015; Wu et al., 2015; Peterson and Horak, 2016). Indeed, the 
dopaminergic insult is most severe in the posterior striatum (i.e. sensorimotor 
putamen) that is involved with motor learning and automaticity (Brooks et al., 1990; 
Poldrack et al., 2005; Wu et al., 2015). Furthermore, step time variability improves 
with dopaminergic replacement therapies in Parkinson’s disease (Figure 1) 
(Hausdorff, et al., 2003a; Schaafsma et al., 2003; Bryant et al., 2016). The dopamine 
depletion in the posterior putamen is also likely to impact on the anterior-to-posterior 
striatal shift (Ashby et al., 2010; Everitt and Robbins, 2016), thus placing additional 
load on the frontal attentional resources that further prevents patients from effectively 
utilizing compensatory locomotor control strategies when automaticity is reduced 
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(Lewis and Barker, 2009; Helmich et al., 2010; Vandenbossche et al., 2012; Lewis 
and Shine, 2014; Wu et al., 2015). Finally, it has often been suggested that 
Parkinson’s patients utilize the cortico-cerebellar pathways involved during early 
motor learning in order to maintain motor functions following the cortico-striatal 
impairments (Hanakawa et al., 1999; Wu and Hallett, 2013; Peterson and Horak, 
2016). However, to date little evidence exists describing the neural mechanisms 
underlying deficits in locomotor automaticity and the role of compensatory strategies 
in Parkinson’s disease due in great part to the mobility restrictions that accompany the 
neuroimaging of gait per se (Shine et al., 2013a; Wu et al., 2015). As such, we 
currently lack a precise understanding of how dopaminergic pathology impairs motor 
automaticity during gait (Vandenbossche et al., 2012; Bohnen and Jahn, 2013; Lewis 
and Shine, 2014; Hamacher et al., 2015; Wu et al., 2015; Peterson and Horak, 2016). 
Furthermore, the role of dopaminergic medication in regulating locomotor 
automaticity in Parkinson’s disease remains poorly understood. Finally, 
understanding compensatory mechanisms for overcoming locomotor automaticity 
impairments in Parkinson’s disease remains an important unresolved clinical question 
(Nonnekes et al., 2015; Wu et al., 2015; Peterson and Horak, 2016).  
 
Approximate Position Figure 1 
 
In this study we set out to investigate the neural mechanisms of dopamine on 
repetitive lower limb movements in Parkinson’s disease. Twenty-three patients with 
Parkinson’s disease performed a virtual reality gait paradigm in conjunction with 
functional MRI both on and off their dopaminergic medication. The virtual reality 
task required patients to either operate foot pedals to navigate a virtual corridor (walk 
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condition) or to watch the screen while a researcher operated the paradigm from 
outside the scanner (watch condition). We hypothesized that in the off medication 
state, patients with Parkinson’s disease would show increased variability in their step 
times as compared to the medicated state, indicative of reduced motor automaticity 
(Hausdorff, et al., 2003b; Yogev et al., 2005; Gilat et al., 2013). We further 
hypothesized that this increase in variability would be associated with increased 
Blood Oxygenation Level Dependent (BOLD) in frontal and parietal cortical regions 
that are associated with the attentional control of movements (Ouchi et al., 2001; 
Bohnen and Jahn, 2013; Wu et al., 2011; 2015; Peterson and Horak, 2016). In 
addition, a recent resting state functional MRI study showed that the strength of 
connectivity across the striatum was significantly reduced in Parkinson patients off 
their dopaminergic medication, which even at rest impacted on large-scale 
sensorimotor network dynamics (Bell et al., 2014). As such, we hypothesized that 
dopamine denervation would also have the strongest effect on the connectivity across 
the striatum during the virtual gait task (Bell et al., 2014), as shown by a significant 
condition (watch, walk) by medication (off, on) interaction effect. Furthermore, we 
hypothesized that dopamine depleted connectivity changes across the striatum would 
correlate with increasing step time variability (Hausdorff, et al., 2003a; Schaafsma et 
al., 2003 Bryant et al., 2016) and impact on the connectivity across large-scale motor 
automaticity and attentional motor control networks involved with gait in Parkinson’s 
disease (Kelly et al., 2009; Helmich et al., 2010; Hacker et al., 2012; Bohnen and 
Jahn, 2013; Bell et al., 2014; Wu et al., 2015).   
 
Materials and Methods 
Study protocol 
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Twenty-three patients with Parkinson’s disease that satisfied the United Kingdom 
Parkinson’s Disease Society Brain Bank clinical diagnostic criteria were recruited for 
this study from the Parkinson’s Disease Research Clinic, Brain and Mind Centre, The 
University of Sydney. None of the patients were diagnosed with dementia according 
to the Movement Disorders Society guidelines (Goetz et al., 2008) or major 
depression according to Diagnostic and Statistical Manual of Mental Disorders-IV 
guidelines of the American Psychiatric Association (Diagnostic and statistical 
manual of mental disorders (4th ed., text rev.)). None of the participants had any 
additional neurological comorbidities including no history of stroke or significant 
head injury. In addition, high-resolution T1-weighted images of each subject passed 
visual inspection by an experienced radiologist for absence of any pathological white 
or grey matter lesions. All patients received dopamine-replacement therapy as part of 
their daily clinical management. Specifically, twelve patients were on levodopa 
monotherapy; two patients were on dopamine agonist monotherapy; four patients 
were on levodopa plus a dopamine agonist; two patients were on levodopa plus a 
monoamine oxidase inhibitor; three patients were on levodopa plus a dopamine 
agonist plus a monoamine oxidase inhibitor. Patients were tested on two separate 
occasions, once whilst on their usual medications and once in the practically defined 
off state, having been withdrawn from their dopaminergic medication overnight for 
more than 12 hours before testing. The order of testing (ON/OFF) was randomized 
and counterbalanced between subjects with a minimum interval of three weeks 
between trials (mean: 7.4 ±5 weeks).  
 
In addition to PD participants, we also acquired imaging data in an independent group 
of twelve healthy age matched control participants (see Materials & Methods: 
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Regions of Interest) that were scanned on a single occasion. The acquisition of 
healthy control data enabled data-driven functional localization of regions involved in 
lower limb motor control during the virtual gait paradigm in an independent and 
matched cohort. Ethical approval for this study was obtained from the University of 
Sydney Human Research Ethics Committee and written informed consent was 
obtained from each subject in accordance with the Declaration of Helsinki. 
 
Cognitive and neurological assessment 
All subjects were assessed on the Mini Mental State Examination. In addition, the 
motor section of the Movement Disorders Society Unified Parkinson’s Disease Rating 
Scale (UPDRS-III) and the Hoehn and Yahr Stages (HY), both on and off 
medications were obtained from patients with Parkinson disease. Motor symptom 
severity was assessed per body side by calculating a sum score of the UPDRS-III 
items for the left and right body side separately (items 3.3-3.8 and 3.15-3.17). The 
body side with the highest sum score on these UPDRS-III items was defined as being 
most affected. Furthermore, item 3 of the Freezing of Gait Questionnaire (FOG-Q3) 
“Do you feel that your feet get glued to the floor while walking, making a turn or 
when trying to initiate walking (freezing)?” was obtained from each subject. Finally, 
dopamine dose equivalency scores were recorded. Cognitive and neurological 
measures were compared between medication states using a paired-samples t-test or 
non-parametric Wilcoxon Signed Rank Sum test (alpha = 0.05). 
 
Virtual Reality Task 
The virtual reality task was performed while subjects lay supine inside the MRI 
scanner. The duration of the task was 10 minutes. The task stimuli were presented on 
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a screen that could be clearly viewed via a mirror mounted onto the head coil. The 
virtual environment consisted of a straight corridor presented in the first person that 
contained no additional environmentally salient or cognitive triggers, which have 
previously been utilised to trigger freezing behaviour (motor arrest) (Figure 2A) ( 
Shine, et al., 2013a; Gilat et al., 2013; 2015). Indeed very little behavioural freezing 
(less than 0.05% of the total paradigm) was observed in the current experiment. 
Progression through this corridor was accomplished by alternately depressing left and 
right foot pedals at least 30° below parallel in a physiological sequence (e.g. left-
right-left-…). Out of sequence steps (left-left or right-right) did not result in forward 
progression and were disregarded from behavioural analyses. Subjects were instructed 
to tap the pedals in a comfortable rhythm as per previous work (Shine, et al., 2013a; 
Gilat et al., 2013; 2015). The paradigm was made up of alternating blocks that 
instructed the participants to perform either of two rules. Walk blocks were initiated 
with the word “WALK” being presented on screen instructing the participants to start 
operating the pedals. In addition, participants performed a control watch block. Watch 
blocks were initiated with the word “WATCH” being presented on screen instructing 
participants to refrain from operating the pedals and watch the screen while a 
researcher operated the task from outside the MRI scanner in a similar rhythm as the 
participants. Subjects were therefore presented with the same visual input and 
baseline cognitive and limbic processes as during walk, without the need for any 
motor activation of the legs. Each block lasted for approximately one minute 
depending on the subject’s latency and was ended when the word “STOP” was 
presented on screen in the colour red. Six seconds after participants had stopped 
accordingly, the alternative of the previous instruction (either “WALK” or 
“WATCH”) was presented. Each participant completed 4-5 alternating blocks of both 
 12 
conditions with the first condition always being a walk block to allow the researcher 
to ensure that the patient had understood the instructions.   
 
Behavioural measures 
Footstep latency was calculated during walk by measuring the time between two 
consecutive foot pedal depressions. The first five steps following a “WALK” cue and 
any step following a “STOP” cue were excluded from the analyses to remove the 
effects of motor initiation and cessation (Georgiades et al., 2016). The mean and 
standard deviation were then used to calculate the coefficient of variation, which is a 
measure of step time variability (Hausdorff, et al., 2003a; Gilat et al., 2013). A 
coefficient of variation in footstep latencies was also calculated for each foot 
separately. A repeated measures ANOVA was then used to investigate the interaction 
between medication (off, on) and symptom side (most affected, least affected) on the 
coefficient of variation for each leg separately. In addition, the coefficient of variation 
was compared between the most- and least affected side using a paired-sampled t-test 
for both medication states. These analyses were performed to assess whether any 
increase in variability may be confounded by asymmetry in symptom severity. No 
behavioural measures were obtained during watch blocks, however all participants 
responded adequately to the “WALK” cue that followed a watch block (<2 seconds 
initiation times), indicating that they were likely to be paying close attention to the 
task. 
   
Neuroimaging 
Image acquisition 
A General Electric 3T MRI was used to obtain T2*-weighted echo planar functional 
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images in sequential order with repetition time (TR)=3s, echo time=32ms, flip 
angle=90°, 32 axial slices covering the whole brain, field of view=220mm, interslice 
gap=0.4mm and raw voxel size=3.9mmx3.9mmx4mm thick. High-resolution 3D T1-
weighted anatomical images with voxel size=0.4x0.4x0.9mm were obtained for co-
registration with functional scans. 
 
Image pre-processing 
Image processing and analyses were performed using Statistical Parametric Mapping 
Software (SPM12, Wellcome Trust Centre for Neuroimaging, London, UK). 
Functional images were pre-processed using the standard pre-processing pipeline 
provided with SPM12. Functional scans were: (i) manually realigned along the 
anterior-posterior commissure; (ii) slice-time corrected to the median (17
th
) slice in 
each scan; (iii) realigned to create a mean realigned image and measures of 6 degrees 
of rigid head movements were created for later use in the correction of minor head 
movements; (iv) unwarped to deal with residual movement related variance induced 
by the susceptibility-by-movement interaction effects; (v) spatially normalized using 
the T1-weighted image to improve segmentation accuracy; (vi) co-registered and 
estimated; and (vii) smoothed using an 8-mm full-width at half maximum isotropic 
Gaussian kernel. Spatial normalization was then manually checked for quality 
assurance.  
 
Head motion correction 
Multiple precautions were taken to ensure head motion was fully accounted for: (i) all 
subjects were instructed to minimize head motion by only moving the ankles, while 
not raising the legs and restrict hip rotation; (ii) cushions were placed inside the head 
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coil to ensure optimal performance with the least amount of head motion; (iii) 
following data collection, trials with >3mm or 3° of scan-to-scan movement were 
considered a-priori exclusion criterion; (iv) six motion and nuisance regressors were 
added into the first level analysis per subject, controlling for minor movement 
artefacts in the three directions of translation and axes of rotation; (v) each trial was 
analysed using ArtRepair (Mazaika et al., 2007) and trials with a large amount of 
global drift or scan-to-scan head movement >1.5mm were corrected using the 
interpolation method; and finally, (vi) mean frame-wise displacement was calculated 
per trial and compared across sessions, showing no significant differences between 
the on and off states (Parkinson patients off versus on: Z=-0.304, p=0.761) or between 
groups (Parkinson patients off versus controls: U=124, Z=-0.487, p=0.644; Parkinson 
patients on versus controls: U=126, Z=-0.417, p=0.694). 
 
Event related Whole Brain analysis 
Individual first-level spatial maps were created in SPM12 using a general linear 
model analysis within an epoch-related design in a fixed-effects analysis. A design 
matrix was created for each subject by entering two regressors for each trial: a 
regressor that modelled the specific onset times and associated temporal derivatives of 
walk blocks and a regressor that similarly modelled the watch blocks. Contrast images 
from the first-level analyses were then entered into a second-level random-effects 
dependent samples t-test design to test the effects of dopaminergic medication within 
the Parkinson’s disease group on the condition of interest (walk>watch), whereas a 
one-sample t-test design was used for the healthy control group. To further investigate 
imaging-behaviour associations, 8mm ROIs were created around the peak voxel for 
each significant second-level cluster found when contrasting walk>watch between 
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medication states in Parkinson’s disease.  
 
In addition, a whole brain parametric modulation analysis was used to investigate 
which brain regions were involved in the modulation of step time variability. First, a 
normalized footstep variability value per TR was calculated for the walk blocks for 
each subject. The normalized footstep variability was calculated as an absolute Z-
score of footstep latencies, which were then de-meaned and averaged per TR. This 
parametric modulator vector was then entered into a general linear model together 
with the six head motion regressors and time derivatives of the hemodynamic 
response function in the first level analysis of SPM12. Contrast images from this 
analysis were then entered into a second-level random-effects analysis: dependent 
samples t-test to investigate differences between dopaminergic states in the 
Parkinson’s disease group; and one-sample t-test analysis for the healthy control 
group. Regions with a negative relationship to the parametric modulator were 
associated with maintaining low step time variability, whereas an increased BOLD 
response indicates that those regions were involved during period of increasing step 
time variability, and hence, worsened automaticity. 
 
The whole brain voxel maps for both analyses were displayed using xjView 
(www.alivelearn.net/xjview) software (p<0.005, k>20) (Lieberman and Cunningham, 
2009) and a threshold-free cluster enhancement (TFCE) for multiple corrections was 
performed on each second level contrast (Smith and Nichols, 2009). To explore the 
direction of pattern in the BOLD responses found in this study, significant clusters 
(See Supplementary Table 3 for MNI coordinates) from the within-Parkinson group 
second level T-maps were saved as images and raw Beta scores were then extracted 
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from these ROIs using the MarsBar toolbox (Brett et al., 2002) in SPM12, the values 
of which were averaged for reporting purposes only.   
 
Task-based functional Connectivity  
In this analysis, we examined the effect of dopaminergic medication on large-scale 
network interactions within and between motor automaticity, attentional motor 
control and striatal networks. Task based functional connectivity in these networks 
was calculated using predefined regions of interest (ROI) as further described below. 
The Response Exploration for Neuroimaging datasets toolbox (Duff et al., 2007) was 
used to extract time series data of each predefined ROI for each patient. Task-based 
functional connectivity was then calculated using the Multiplication of Temporal 
Derivatives statistical method (Shine et al., 2015). This method allows greater 
temporal resolution of time-resolved connectivity in BOLD time series data when 
compared to the conventional sliding-window Pearson’s correlation coefficient (Shine 
et al., 2015; 2016). The code is freely available at 
http://github.com/macshine/coupling/ (Shine et al., 2015; 2016). First, mean 
functional connectivity was calculated within and between each network of interest 
and entered into condition (watch, walk) by medication (on, off) repeated measures 
ANOVAs (alpha = 0.05, False Discovery Rate (FDR) correction 0.05). For significant 
interactions post-hoc correlations were performed to further examine whether the 
task-based functional connectivity was associated with worse step time variability. 
Furthermore, to examine whether striatal dopamine modulated the communication 
across large-scale networks, we further examined the effects of dopamine on internal 
network connectivity. A correlation analysis was performed on the amount of 
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functional connectivity during walk in the on state compared to the off state (on-off) 
for the connectivity across each network.  
 
Regions of Interest 
Regions of interest were defined using a combination of data-driven regions identified 
using the age-matched healthy control group during performance of the virtual gait 
task and pre-defined a priori regions shown to be involved in attentional motor 
control in Parkinson’s disease and the striatum (see Supplementary Materials: 
Regions of Interest for full description). Defined regions of interest were then utilized 
for subsequent functional connectivity analyses (see Supplementary Table 2 for MNI 
coordinates). These regions composed three different networks: motor automaticity, 
attention motor and striatal networks. 
 
Motor Automaticity Network 
As it is currently unclear how lower limb motor automaticity is achieved, data from 
the twelve matched healthy control subjects was used to explore which brain regions 
would be involved with the performance of the virtual reality task (walk>watch), and 
specifically to identify which brain regions would be associated with maintaining low 
step time variability. Based on this data-driven approach we included the bilateral 
primary motor cortex area of the legs, thalamus, putamen, superior orbitofrontal 
gyrus, lateral cerebellum and anterior cingulate into the motor automaticity network. 
In addition, the cerebellar locomotor and bilateral mesencephalic locomotor regions 
were included as predefined a-priori regions of interest (See Supplementary 
Materials: Regions of Interest and Supplementary Table 1 and Table 2 for MNI 
coordinates).  
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Attention Motor Network 
The low variability in step times seen in the healthy control participants did not allow 
for the investigation of the attention demanding cortical regions that are hypothesized 
to be associated with high step time variability in the Parkinson’s disease group 
following dopamine depletion (Wu and Hallett, 2005; Yogev et al., 2005; Bohnen and 
Jahn, 2013; Lewis and Shine, 2014; Clark, 2015; Wu et al., 2015; Peterson and 
Horak, 2016). As such, predefined ROIs were created for regions that have been 
shown to be involved with the attentional control of movements in Parkinson’s 
disease, including the dorsal lateral prefrontal cortex (DLPFC), pre-supplementary 
motor area (pre-SMA), dorsal premotor cortex (PMd) and posterior parietal cortex 
(PPC) (Cole and Schneider, 2007; Kurz et al., 2012; Shine, et al., 2013b; Wu et al., 
2011; 2015).  
 
Striatal Network 
The striatal network consisted of seven predefined regions of interest in the striatum 
of each hemisphere in the Parkinson’s disease group, as described by Bell et al. (Bell 
et al., 2014). These striatal regions correspond to dissociable functional systems (Di 
Martino et al., 2008; Kelly et al., 2009) and enable broad coverage of the striatum 
(Bell et al., 2014). The ROIs included the bilateral: inferior ventral striatum (VSi), 
superior ventral striatum (VSs), dorsal caudate (DC), dorsal caudal putamen (DCP), 
dorsal rostral putamen (DRP), ventral rostral putamen (VRP) and postcommissural 
putamen (PCP) ( Di Martino et al., 2008; Kelly et al., 2009; Bell et al., 2014). Based 
on the study by Di Martino and colleagues (2008) we further defined the caudal 
putamen seeds (DCP and PCP) as being most involved with sensorimotor tasks, the 
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dorsal caudate (DC) with cognitive control and the inferior ventral striatum (VSi) 
seeds, which approximate the nucleus accumbens, with limbic processing (Di Martino 
et al., 2008). These seeds were used to define striatal cognitive-motor, limbic-motor 
and limbic-cognitive connections during a post-hoc analysis, as further described 
below.  
 
 
Results 
Participant demographics and behavioural outcomes 
Patients with Parkinson disease and healthy control subjects were matched across 
multiple demographics (see Supplementary Table 4). The Parkinson’s disease patients 
had a mean levodopa equivalent daily dose of 861 (±525) and disease duration (in 
years) of 6 ( ± 2.9). Patients demonstrated clinical improvement following 
dopaminergic treatment, as indicated by a significantly lower UPDRS-III score and 
HY stages in the on state (Table 1). The current cohort consisted of patients with a 
range of freezing of gait severity, with eight subjects scoring a 0 (‘Never’), six 
subjects scoring a 1 (‘Very rarely’) and nine subjects scoring >1 (‘Rarely-Often-
Always’) on the FOG-Q3. Importantly, Parkinson’s disease patients off medication 
had similar modal footstep latencies as compared to when medicated, which together 
with similar scores on UPDRS-III items 3.7 (toe tapping) indicate that any group 
differences found were unlikely to be driven by an overall difference in lower limb 
motor performance (e.g. rigidity) (Table 1). However as predicted, step time 
variability was significantly higher in Parkinson patients off their medication as 
compared to when on medication (Table 1), suggesting between group differences in 
motor automaticity. Indeed, no significant interaction effect was found between 
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medication (off, on) and symptom side severity (most affected, least affected) on the 
coefficient of variation of footstep latencies (F=0.992, p=0.330). This analysis also 
revealed no main effect of medication (F=2.698, p=0.115) or main effect of symptom 
side severity (F=0.598, p=0.448). Furthermore, a difference score in toe tapping 
ability between the most- and least affected side did not significantly correlate with 
the coefficient of variation in footstep latencies in either medication state (Spearman 
correlation OFF: ρ=0.318, p=0.139; ON: ρ=-0.311, p=0.149). Together, these results 
indicate that the change in step time variability seen between medication states did not 
reflect asymmetry in symptom severity.  
 
 
Table 1: Demographic and Behavioural Statistics within the Parkinson’s disease 
group (n=23) during different medication states (off/on).  
Task OFF ON Test-value P-value 
UPDRS-III 27.8 (14) 22.9 (14) 2.62 0.015
 a
 
HY 2 (1-3) 2 (1-3) -2.12 0.034
b
 
Toe-Tap Right 1 (0-3) 1 (0-4) -0.428 0.669
 b
 
Toe-Tap Left 1 (0-3) 1 (0-3) -0.775 0.439
 b
 
Modal FSL 0.48 (0.15) 0.48 (0.12) -0.011 0.991
 a
 
CV 29.6 (20) 16.4 (8.3) 3.50 0.002 
a
 
NOTE: UPDRS-III = Movement Disorder Society Unified Parkinson’s Disease 
Rating Scale motor section III, Toe-Tap = Scores on item 3.7 of the Movement 
Disorder Society Unified Parkinson’s Disease Rating Scale, Modal FSL = Modal 
Footstep Latency during performance of walk in the virtual reality task, CV = 
Coefficient of Variation in footstep latencies during the performance of walk in 
the virtual reality task. 
a
Paired-samples t-test used and Mean (SD) and t-value 
reported, 
b
Non-parametric Wilcoxon Signed Ranks Test used and Median 
(Range) and Z-value reported for ordinal variables. 
 
 
Neuroimaging results 
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Whole brain activation (walk>watch) 
The dopamine-depleted state of Parkinson’s disease was associated with a 
significantly positive BOLD response in the bilateral orbitofrontal cortex during walk 
compared to negative BOLD during watch (TFCE corrected, see Figure 2B and 
Supplementary Table 3 for peak voxel coordinates). In addition, within-group 
analysis revealed that in both medication states patients demonstrated activation of the 
primary motor cortex. However, when on medication patients also utilized the pre-
supplementary motor area, visual cortex and cerebellum, whereas patients off 
medication utilized the right mid frontal gyrus and bilateral orbitofrontal cortex (see 
Supplementary Figure 2). For exploration (i.e. non-statistical) purposes only, post-hoc 
one-sampled and paired-sampled t-tests were performed on the mean beta values in 
the orbitofrontal clusters that were found to be significantly different between 
medication states on the condition of interest (walk>watch) (See Figure 2C). These 
results confirmed that in the off state, the beta values in the orbitofrontal clusters were 
significantly different from zero during both WALK and WATCH blocks (all p<0.01, 
Bonferonni corrected) and significantly different between WALK and WATCH 
blocks (Left orbitofrontal: t=4.36, p<0.001; Right orbitofrontal: t=5.42, p<0.001, 
Bonferonni corrected).  No differences in beta values were found for both 
orbitofrontal clusters in the dopaminergic on state between WALK and WATCH 
blocks (Left orbitofrontal: t=0.560, p=0.592; Right orbitofrontal: t=0.881, p=0.151), 
which were also not significantly different from zero (all p>0.1). 
 
Approximate Position Figure 2 
 
Whole brain activation (Parametric Modulator) 
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The goal of this analysis was to identify regions that were consistently associated with 
greater step time variability. The BOLD responses associated with the parametric 
modulator in the Parkinson’s disease group are presented in Figure 3. In the off state 
Parkinson’s disease patients had significant negatively signed beta values across the 
right dorsal premotor cortex and left posterior parietal cortex in contrast to the slight 
positively signed beta values in these regions in the on state (Figure 3 C and 3 E). 
This suggests that a negative association exists between BOLD response in these 
regions and step time variability in the off state. Furthermore, patients on medication 
had significant positively signed beta values in the right lateral cerebellum compared 
to the off state (Figure 3 C and 3 E), indicating that the cerebellar regions were 
recruited during periods of increasing step time variability when medicated, although 
these findings did not survive TFCE correction for multiple comparisons. As tremor 
amplitude in Parkinson’s disease has previously been associated with increased beta 
values in the cerebellum (Helmich et al., 2012), a post-hoc Spearman correlation 
analysis was performed between the sum score of UPDRS-III tremor items 3.15-3.18 
and the beta weights of the right cerebellum cluster found to be significantly 
associated with the parametric modulator. The results showed no significant 
correlations between tremor scores and cerebellar Beta weights for both medication 
states (OFF: ρ=0.199, p=0.362; ON: ρ=0.142, p=0.517), indicating that tremor was 
unlikely to explain the results found. 
 
To explore whether Parkinson patients utilized a cortico-cerebellar network in order 
to operate movements as a compensation for cortico-striatal impairments (Rascol et 
al., 1997; Doyon et al., 2002), a post-hoc correlation analysis was performed between 
the loading of the parametric modulator regressor onto the right lateral cerebellum 
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that was found to be significant during the parametric modulator analysis contrast 
(OFF>ON, see Figure 3 C) and the functional connectivity within the attention motor 
control network. A positive correlation was found between the loading of the 
variability regressor onto the right lateral cerebellum and the total functional 
connectivity within the regions of the cognitive network for the Parkinson’s disease 
group when off medication (r=0.452, p=0.030, uncorrected), whereas the negative 
correlation found when patients were medicated did not reach statistical significance 
(r=-0.246, p=0.259) (Figure 3 F). 
 
Approximate Position Figure 3 
 
Task-based functional connectivity  
As predicted a significant main effect of condition was found for all network 
connections showing an increased functional connectivity during walk as compared to 
watch (see Supplementary Figure 3, FDR corrected). Furthermore, a significant main 
effect of medication was found within the attention motor network (FDR corrected, 
see Figure 4). A significant condition (watch, walk) by medication (off, on) 
interaction effect was found within the striatum (F(1,22)=5.022, p=0.035, 
uncorrected, see Figure 4). Post hoc simple effect analysis showed that patients on 
medication were able to increase internal functional connectivity within the striatal 
network during walk compared to watch (Mean difference=0.367, p=0.003, FDR 
corrected), whereas patients off medication were not (Mean difference=0.106, 
p=0.285).  
 
To examine how striatal dopamine modulates the interactions across large-scale 
networks, we further examined the effects of dopamine on internal network 
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connectivity. Results showed that dopaminergic modulation of the striatal network 
significantly correlated with the degree of dopaminergic modulation of internal motor 
automaticity network (r=0.536, p=0.008, Bonferonni corrected) and internal attention-
motor network connectivity (r=0.464, p=0.026, uncorrected). As expected, there was 
no relationship between dopaminergic modulation of the attention-motor network and 
motor automaticity networks (r=0.219, p=0.315), indicating that the dopaminergic 
innervation of the striatum may be a key driving factor in modulating dopamine 
mediated change in functional connectivity in other large-scale networks.  
 
Approximate Position Figure 4 
 
Imaging-Behaviour Associations  
We further examined the relationship between the major imaging findings in this 
study and behaviour, in order to explain how breakdown in network communication 
perturbs locomotor automaticity in the dopamine depleted state. Following the 
significant condition by medication interaction effect within the striatum, a post-hoc 
correlation analysis was performed between the amount of functional connectivity 
within the striatum during walk and step time variability (Bonferonni corrected for 
multiple comparisons). Internal striatal functional connectivity during walk correlated 
strongly with increasing step time variability in the off state (r=0.616, p=0.002), 
whereas no such correlation was found in the on state (r=-0.233, p=0.284). To further 
explore these findings, a separate post-hoc analysis was performed to see which 
striatal circuit (e.g. cognitive-motor, limbic-motor or limbic-cognitive) was driving 
this correlation with step time variability during walk (Figure 5A-B). Interestingly, a 
significant correlation was found between step time variability and the functional 
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connectivity in the striatal limbic-motor (r=0.688, p<0.001) and limbic-cognitive 
(r=0.597, p=0.003) circuits, whereas the cognitive-motor (r=0.380, p=0.068) 
functional connectivity did not reach statistical significance (Figure 5A-B). No 
significant correlations were found in the on state (limbic-motor: r=-0.153, p=0.487; 
limbic-cognitive: r=-0.227, p=0.297; cognitive-motor: r=-0.142, p=0.519). 
 
As aforementioned, the whole brain analysis comparing walk>watch between 
medication states revealed increased bilateral BOLD responses in the orbitofrontal 
cortex in the off state (see Figure 2). The orbitofrontal cortex is known to have 
connections with multiple areas of the striatum allowing it to adapt behaviour (Haber 
et al., 1995; Schoenbaum et al., 2009; Rolls, 2015). As such, to explore its influences 
in the current study a second post-hoc analysis was performed to investigate whether 
the functional connectivity between the orbitofrontal cortex (see supplementary table 
3 for MNI coordinates) and intra-striatal circuits was correlated with step time 
variability (Figure 5C). The results showed that the functional connectivity between 
the bilateral orbitofrontal cortex and inferior ventral striatum (limbic, r=0.653, 
p<0.001) and dorsal putamen seeds (motor, r=0.643, p<0.001) were significantly 
correlated to step time variability in the off state (Bonferonni corrected for multiple 
comparisons), whereas no correlation was found between step time variability and the 
functional connectivity between the orbitofrontal cortex and dorsal caudate nucleus 
(cognitive, r=0.293, p=0.174) (Figure 5C). Again no significant correlations were 
found in the on state (motor: r=-0.323, p=0.132; cognitive: r=-0.167, p=0.447; limbic: 
r=-0.304, p=0.159).  
 
Approximate Position Figure 5 
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Finally, it has been proposed that local depletion of dopamine levels within the 
striatum in Parkinson’s disease can lead to a reduced ability to consecutively process 
information through complementary yet competing cortico-striatal neural pathways 
(e.g. motor, cognitive and limbic pathways), which may eventually result in the 
inhibition of brainstem locomotor centres (Lewis and Barker, 2009; Lewis and Shine, 
2014). We therefore wanted to explore whether the increased striatal limbic functional 
connectivity in Parkinson’s disease patients off medication could have been 
influenced by a reduced ability to integrate this information into the consecutive 
motor or cognitive cortico-striatal pathways. As such, a post-hoc analysis was 
performed by correlating the degree of functional connectivity within the striatal 
limbic circuits (e.g. limbic-motor and limbic-cognitive) with the amount of functional 
connectivity between the primary motor cortex and dorsal putamen (motor cortico-
striatal loop) and between the dorsolateral prefrontal cortex and dorsal caudate 
(cognitive cortico-striatal loop) (Figure 6A). Results showed that during the on state, 
the functional connectivity in intra-striatal limbic circuits correlated strongly with the 
functional connectivity between regions of the cognitive cortico-striatal loop (striatal 
limbic-motor: r=0.615, p=0.002; striatal limbic-cognitive: r=0.711, p<0.001), but not 
the motor cortico-striatal loop (striatal limbic-motor: r=-0.125, p=0.569, limbic-
cognitive: r=0.204, p=0.351) (Figure 6B-C). Interestingly, no significant correlations 
were found in the off medication state for either the cognitive cortico-striatal loop 
(striatal limbic-motor: r=-0.189, p=0.387; limbic-cognitive: r=0.077, p=0.728) or the 
motor cortico-striatal loop (striatal limbic-motor: r=0.080, p=0.718; limbic-cognitive: 
r=0.074, p=0.738). 
 
Approximate Position Figure 6 
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Discussion 
 
To our knowledge, this is the first study to investigate the role of dopamine on the 
neural mechanisms underlying lower limb motor automaticity impairments in 
Parkinson’s disease. Twenty-three patients with Parkinson’s disease performed an 
interactive virtual reality paradigm consisting of two conditions (walk, watch) in 
conjunction with functional MRI both on and off dopaminergic medication. The main 
results were: (i) Parkinson’s disease patients had greater step time variability off 
dopaminergic medication and recruited the bilateral orbitofrontal cortex when 
performing lower limb movements in the virtual reality task, as compared to when 
appropriately medicated; (ii) in the dopamine-depleted “off” state, patients with 
Parkinson’s disease demonstrated an over-reliance on regions associated with 
cognitive control, which is in contrast to the recruitment of the cerebellum to maintain 
low variability in the “on” state; (iii) dopamine had a demonstrable influence on intra-
striatal functional connectivity during lower limb movements; (iv) in the dopamine 
depleted-state, functional connectivity in orbitofrontal-striatal limbic circuits was 
correlated with step time variability; (v) with the administration of dopamine, the 
aforementioned striatal limbic circuits became coupled with cognitive cortico-striatal 
pathways that are putatively used to integrate the limbic information in order to 
maintain effective motor performance. 
 
As predicted, patients with Parkinson’s disease demonstrated an increased step time 
variability during the virtual reality gait task in the dopamine depleted state compared 
to when medicated, indicative of a loss of motor automaticity (Hausdorff, 2003b; 
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Yogev et al., 2005; Plotnik et al., 2011; Kelly et al., 2012; Gilat et al., 2013). This 
finding is in accordance with a broad literature showing that dopaminergic medication 
improves step time variability during over ground walking in Parkinson’s disease 
(Hausdorff, et al., 2003b; Schaafsma et al., 2003; Bryant et al., 2016) and is thought 
to indicate a shift from an automated towards a more attention demanding cognitive 
strategy of motor control (Bohnen and Jahn, 2013; Clark, 2015; Peterson and Horak, 
2016).  
 
During the walk condition, patients with Parkinson’s disease in the dopamine depleted 
state demonstrated significantly greater BOLD activation across the bilateral 
orbitofrontal cortex compared to the on state (TFCE corrected). The orbitofrontal 
cortex is involved in many functions including modulation of attention and goal-
directed behaviour (Rolls and Grabenhorst, 2008; Lewis and Barker, 2009; Takahashi 
et al., 2011; Hartikainen et al., 2012; Marinelli et al., 2015;). These findings are in 
accordance with Ouchi et al. (2001) who used dopamine transporter PET imaging 
(DAT and 
[11C]
CFT) to show that Parkinson’s disease patients off their medication 
have significantly increased activation in dopaminergic neurons of the bilateral 
orbitofrontal cortices during continuous straight walking, whereas gait in healthy 
controls activated the dopaminergic neurons in the putamen (Ouchi et al., 2001). 
Importantly, orbitofrontal 
[11C]
CFT uptake in Parkinson’s disease was inversely 
correlated with cadence during gait (Ouchi et al., 2001).  
 
The novel parametric modulator analysis used in the current study showed that during 
periods of increasing variability Parkinson’s disease patients on medication engaged 
the bilateral cerebellum, a key hub known to be important for automated feed-forward 
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control of motor timing and adaptation (Rand et al., 1998; Lang and Bastian, 1999; 
Doya, 2000; Morton and Bastian, 2006; Wu and Hallett, 2013). Recruiting this region 
may have allowed patients on medication to appropriately adapt to sudden changes in 
step timing variability without the need for attentional control (Horak and Diener, 
1994; Rand et al., 1998; Doya, 2000; Morton and Bastian, 2006)Without 
dopaminergic medication however, the same patients became unable to recruit the 
cerebellum and instead relied on cortical regions associated with cognitive control. 
The slow and serial processing of these cognitive resources (Schneider and Chein, 
2003) could have required a longer time for peripheral information to be integrated 
with the stepping pattern resulting in a higher step time variability (Lucas et al., 2013; 
Shine, et al., 2013a; Clark, 2015; Hamacher et al., 2015). These results however did 
not survive TFCE correction for multiple comparisons, warranting cautious 
interpretation. 
 
A post-hoc analysis further showed that the loading of the variability regressor onto 
the cerebellum correlated significantly with the amount of functional connectivity 
within the attentional motor network in the off state. This novel finding could reflect a 
compensatory increase in network level organization where the attentional motor 
network might be attempting to engage the cerebellum following a loss of motor 
automaticity in the striatum (Wu et al., 2009; 2011), although seemingly failing to do 
so. As the cerebellum receives relatively minor dopaminergic innervation (localized 
mostly in the vermis) (Melchitzky and Lewis, 2000) but shares strong reciprocal 
connections to the basal ganglia (Morton and Bastian, 2004; Bostan et al., 2013), it 
could be through functional coupling with the basal ganglia, that dopamine modulates 
cerebellar circuits. The failure to recruit the cerebellum in the off state of Parkinson’s 
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disease could therefore be the result of impaired basal ganglia – cerebellar coupling 
(Morton and Bastian, 2004; Bostan et al., 2013). This is in accordance with previous 
resting state functional MRI studies showing reduced functional coupling between the 
striatum and the cerebellum in the dopamine depleted state of Parkinson’s disease 
(Hacker et al., 2012; Jech et al., 2013; Bell et al., 2014).  
 
Striatal dysfunction can lead to an over-activation of the output nuclei of the basal 
ganglia (e.g. subthalamic nucleus and globus pallidus internus) that send inhibitory 
GABAergic projections to the cerebellum (via the pontine nuclei), thus hampering 
cerebellar compensation abilities in Parkinson patients off medication (Lewis and 
Barker, 2009; Bostan et al., 2013; Lewis and Shine, 2014). This is further evidenced 
by an increase in neuronal activation of deep cerebellar nuclei following high-
frequency stimulation of the subthalamic nucleus in rats (Moers-Hornikx et al., 2011) 
and normalized cerebellar activation in patients with Parkinson’s disease that received 
subthalamic deep brain stimulation (Asanuma et al., 2006; Grafton et al., 2006; Hill et 
al., 2013; Wu and Hallett, 2013). Future studies are encouraged to further investigate 
these important dopamine related compensatory and pathological alterations in 
striatal-cerebellar and cortico-cerebellar networks during gait in Parkinson’s disease 
(Wu and Hallett, 2013). In addition, these results lend weight to investigating the 
potential therapeutic implications of non-invasive cerebellar stimulation techniques 
(e.g. transcranial magnetic stimulation) to improve gait in patients with Parkinson’s 
disease (Koch et al., 2008). The cerebellum also shares connections with the frontal 
and parietal cortices via the thalamus, which is also intimately involved in cortico-
basal ganglia circuitry (Lewis and Barker, 2009; Bohnen and Jahn, 2013; Verlinden et 
al., 2016). It is therefore somewhat surprising that the current study did not find any 
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significant thalamic influence on step time variability. For instance, higher white 
matter microstructure radiations between the thalamus and cortical and cerebellar 
regions have recently been shown to be associated with improved gait measures, 
including step width variability in healthy elderly (Verlinden et al., 2016). Future 
studies specifically examining thalamic-cortical connectivity as a function of motor 
automaticity may be more sensitive to the effects of dopamine on thalamic circuitry. 
In addition, it remains to be determined whether white matter changes are associated 
with increased gait variability in Parkinson’s disease. The negative association found 
in the off state between step time variability and BOLD responses of the right dorsal 
premotor cortex and left posterior parietal cortex indicate that Parkinson’s disease 
patients are unable to bring these brain regions online, leading to increasing step time 
variability. Alternatively, patients may have utilized these cortical regions as a 
compensatory strategy to improve their stepping performance in the off state. Future 
studies are now needed to test these hypotheses, as causality could not be inferred 
from these results. 
 
The functional connectivity analysis revealed a significant main effect of condition 
where each within and between network connection significantly increased its 
functional connectivity during walk compared to watch, highlighting the involvement 
of these predefined networks in lower limb motor performance in Parkinson’s disease 
(Lewis and Barker, 2009; Bohnen and Jahn, 2013; Hamacher et al., 2015; Wu et al., 
2015; Peterson and Horak, 2016). Furthermore, a significant main effect of 
medication was found within the attentional motor network, showing overall 
increased functional connectivity in the off state. This dopaminergic effect likely 
reflects the attentional compensatory strategy employed by Parkinson patients off 
 32 
medication as a result of impaired striatal functioning (Bohnen and Jahn, 2013; Clark, 
2015; Wu et al., 2015). Indeed, the dopaminergic innervation of the striatum 
significantly correlated with the effects of dopamine within the other networks, 
reflecting the importance of striatal dopamine in large-scale network function during 
lower limb movements (Kelly et al., 2009; Jech et al., 2013; Bell et al., 2014). 
Furthermore, a significant condition by medication interaction effect was found 
within the striatum. This finding advances previous resting state functional MRI 
studies by showing that impaired integration across striatal subdivisions in the 
dopamine depleted state of Parkinson’s disease found during rest also affects lower 
limb motor performance (Helmich et al., 2010; Surmeier et al., 2010; Hacker et al., 
2012; Sharman et al., 2013; Bell et al., 2014).  
 
To our knowledge, this study is the first to show that impaired crosstalk across the 
dopaminergically-depleted striatum of Parkinson’s disease correlates with increased 
step time variability. Furthermore, our post-hoc analyses revealed that intra-striatal 
limbic circuits were driving this correlation with worse step time variability. In fact, 
the functional connectivity within the orbitofrontal-ventral striatum limbic circuit was 
strongly correlated with increased step time variability in the dopamine depleted state. 
The current study therefore provides novel pathophysiological evidence to suggest 
that activation in the orbitofrontal cortex during gait in Parkinson’s disease is related 
to activity within a limbic cortico-striatal circuit that, in the context of reduced 
dopamine, interferes with the striatal control of lower limb motor function. 
 
Our findings are supported by primate work showing that the terminals of the 
orbitofrontal cortex are extensive throughout the dopaminergic neurons, which 
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influence a wide area of the striatum, particularly the ventral striatum and core of the 
nucleus accumbens (Haber et al., 1995). Furthermore, a resting state functional MRI 
study by Di Martino et al. (2008) showed that in healthy adults the spontaneous 
fluctuations in BOLD response in the inferior ventral striatum primarily correlated 
with the orbitofrontal cortex, indicating that strong functional connections exist 
between these regions in humans (Di Martino et al., 2008). Yang et al. (2016) also 
recently showed that functional connectivity during rest was increased between the 
ventral striatum and orbitofrontal cortex in Parkinson’s disease patients off 
dopaminergic medication as compared to when medication, indicating that dopamine 
has a profound influence on this orbitofrontal-striatal limbic circuitry (Yang et al., 
2016).  
 
The striatal projections allow the orbitofrontal cortex to regulate motor actions under 
the influence of dopamine, for instance to adapt behaviour in the face of unexpected 
outcomes (Schoenbaum et al., 2009; Takahashi et al., 2009; Rolls, 2015). It has 
previously been proposed that error signals processed by the midbrain dopaminergic 
neurons that project to the striatum originate within regions of the orbitofrontal cortex 
that encode expected value and performance outcome, and which later connect to the 
ventral striatum (Takahashi et al., 2011; Rolls, 2015). The orbitofrontal cortex indeed 
receives negative prediction error feedback (i.e. sensory evidence that did not match 
the predicted performance outcome) from every sensory system, making it an 
important hub for multisensory integration that enables planning and learning 
performance outcomes (Kringelbach, 2005; Schoenbaum et al., 2009; Takahashi et 
al., 2009; Goble et al., 2011; Rolls, 2015; Chanes and Barrett, 2016). As Parkinson’s 
disease patients have known sensorimotor impairments (Nolano et al., 2008; Conte et 
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al., 2013; Ehgoetz Martens et al., 2013; Lucas et al., 2013), the increased BOLD 
responses found in the orbitofrontal cortex in the Parkinson group off medication 
could reflect an attempt to adapt behaviour following increased negative prediction 
error feedback (Kringelbach, 2005; Schoenbaum et al., 2009; Takahashi et al., 2009). 
Indeed, our results further showed that increased intra-striatal limbic functional 
connectivity was correlated with increased functional connectivity within regions of 
the cognitive cortico-striatal pathway selectively in the “on” state. This might indicate 
that with sufficient dopaminergic resources, the striatum is able to functionally 
integrate limbic information into the parallel cortico-striatal pathways, which can then 
provide top-down control over motor performance to resolve the prediction error and 
prevent motor deterioration (i.e. compensation) (Postuma and Dagher, 2006; Lewis 
and Barker, 2009; Rolls, 2015). However, dopamine depletion likely impairs such 
parallel cortico-striatal integration within the striatum, as evidenced by the lack of 
such correlations in “off” state (Lewis and Barker, 2009; Bell et al., 2014; Wu et al., 
2015). The prediction error would therefore remain unresolved and hence, continue to 
induce an increased limbic drive within the striatal network. This could impair motor 
performance directly by innervating the inhibitory basal ganglia output structures that 
project to the brainstem locomotor centres ( Lewis and Barker, 2009; Lewis and 
Shine, 2014). In addition, the increased limbic drive likely demands a proportion of 
the depleted dopaminergic resources within the striatum, further depriving the dorsal 
striatum from its ability to process automated motor sequences (Wu et al., 2015). 
Therefore, based on the results of the current study, it can be postulated that although 
the ventral striatal-orbitofrontal circuit may usually be employed as a compensatory 
strategy to overcome negative error feedback, without sufficient dopaminergic 
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resources utilizing this network can actually deteriorate motor performance in 
Parkinson’s disease patients. 
 
This study now forms the basis for future work. The orbitofrontal cortex has 
previously been associated with the integration of emotional information into decision 
processes (Bechara et al., 2000). In addition, anxiety and depression are associated 
with impaired gait performance in Parkinson’s disease patients (Rochester et al., 
2004; 2005; Lord et al., 2011; 2013; Ehgoetz Martens et al., 2015;), and these deficits 
are amenable to dopaminergic medication (Ehgoetz Martens et al., 2015). Previous 
authors have postulated that depression and anxiety impair goal-directed attentional 
processing (Rochester et al., 2004; 2005), possibly by increasing computational load 
of the ventral striatum-orbitofrontal pathway resulting in response conflict in the 
dopamine depleted cortico-basal ganglia motor circuitry (Lewis and Barker, 2009; 
Ehgoetz Martens et al., 2013; 2015). Future studies should therefore investigate the 
complex interaction between dopamine, mood disturbance and gait impairments in 
Parkinson’s disease.  
 
In addition, the current patient cohort consisted mostly of patients with moderate 
bilateral disease (1 subject scored HY=1; 18 subjects scored HY=2-3; 3 subjects 
scored HY=3 and no subjects scored HY>3). As such, future work is needed to 
investigate whether the neural basis underlying gait variability changes with disease 
severity. Furthermore, it is recommended that future studies account for laterality in 
brain pathology when analysing neuroimaging data in a cohort of Parkinson’s disease 
patients with obvious unilateral symptom severities. It is also important to note that 
although dopamine evidently plays a key role, gait disturbances in Parkinson’s 
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disease likely reflect a multisystem neurodegenerative disorder beyond the loss of 
dopaminergic neurons, especially as the disease progresses (Bohnen and Albin, 2011; 
Bohnen and Jahn, 2013; Bohnen et al., 2013). For instance, prefrontal cholinergic 
neurons are key players in attentional control functions that may be put under 
increasing pressure following striatal and prefrontal deterioration in Parkinson’s 
disease (Bohnen et al., 2013; Gonzales and Smith, 2015). Gait speed has indeed been 
shown to be most affected in patients with both nigrostriatal dopaminergic and 
cortical cholinergic denervation (Bohnen et al., 2013). Future studies using larger 
cohorts are now needed to investigate the role of dopaminergic, cholinergic and other 
neurotransmitter systems on gait automaticity impairments and freezing of gait in 
Parkinson’s disease and Parkinson’s disease subgroups, for example Parkinson’s 
disease patients with and without freezing of gait (Bohnen and Albin, 2011; Bohnen 
et al., 2014).  
 
Furthermore, dual task interference provides an alternative avenue to study motor 
automaticity impairments (Yogev et al., 2005; Kelly et al., 2012; Wu et al., 2015). 
Future studies are therefore encouraged to further evaluate dual task interference to 
confirm that the increased step time variability seen in the Parkinson’s disease 
patients off medication reflects reduced motor automaticity (Poldrack et al., 2005; Wu 
et al., 2015). However, similar to walking and most daily behaviours, simple motor 
tasks such as foot tapping are usually performed automatically in healthy subjects 
(Wu et al., 2015). Furthermore, once a motor task is automatic it becomes difficult to 
revert back to controlled behaviour (Schneider and Chein, 2003; Wu et al., 2015). It 
can therefore be assumed that the performance in healthy control participants and low 
variability seen in Parkinson’ s patients on medication indicated a more automatic 
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motor performance. In addition, a supplementary correlation analysis was performed 
between the functional connectivity values and another behavioural motor outcome of 
the virtual reality paradigm, namely modal footstep latency, showing no significant 
correlations (See Supplementary Table 4). This further indicates that the findings of 
the current study are indeed specific to step time variability and thus motor 
automaticity. In accordance with the findings in this study, previous behavioural 
research has shown that the administration of dopaminergic replacement therapy often 
improves step time variability in Parkinson’s disease patients (Hausdorff, et al., 
2003a; Lord et al., 2011; Rochester et al., 2011; Bryant et al., 2016). Furthermore, 
impairments in dual-task walking are also often improved by optimal dopaminergic 
replacement therapy (Camicioli et al., 1998; Lord et al., 2011; Elshehabi et al., 2016). 
Together, this evidence suggests that dopaminergic therapy may influence gait-related 
neural computations through modulation of motor automaticity. 
 
While multiple motor skills rely upon motor automaticity, in this study, step time 
variability was employed as a surrogate for motor automaticity in an attempt to model 
simple gait. Equally, however, dual task paradigms can also provide insights into the 
breakdown of automaticity in Parkinson’s disease by loading additional attentional 
resources with overt task demands. Future studies are now needed to further 
investigate the interaction between dopamine and dual tasking ability during gait in 
patients with Parkinson’s disease. Finally, a limitation inherent in the study of motor 
automaticity is that indirect surrogate measures are required. Therefore, the 
component processes by which dopaminergic replacement therapy improves motor 
skills cannot be precisely isolated. While it is hypothesized that dopamine 
replacement therapy exerts its major mechanism of action by improving motor 
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automaticity in subcortical structures leading to reduced step time variability, 
dopamine may also modulate other sub-processes including, coordination, balance, 
proprioception, affective processing and cognition that may affect step time 
variability and motor automaticity. 
 
In conclusion, this study showed that dopamine depletion in Parkinson’s disease 
impairs motor automaticity by reducing striatal functioning and cerebellar 
compensation strategies, which lead to increased attentional motor control and 
excessive orbitofrontal-striatal limbic interference. 
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Figure Legends 
Figure 1: Schematic representation of the locomotor automaticity processes in health 
and hypothesized neural mechanisms underlying automaticity impairments in 
Parkinson’s disease with and without dopaminergic replacement therapy. Left image 
– hypothesized posterior motor network underlying locomotor automaticity in health; 
Middle image – dopaminergic pathology in posterior striatum in Parkinson’s disease 
is thought to cause patients to utilize attention demanding cortical resources to operate 
gait; Right image – dopaminergic replacement therapy is thought to normalize 
locomotor automaticity impairments in Parkinson’s disease. NOTE: “Off”=Dopamine 
depleted state; “On”=On dopaminergic replacement therapy. 
 
 
Figure 2: Whole Brain analysis for walk>watch. A=visual representation of the virtual 
reality task; B=BOLD responses within the Parkinson’s disease group (n=23) between 
medication states (off>on) on the condition of interest (walk>watch); p<0.005, k>20, 
TFCE corrected. 
 
 
Figure 3: BOLD responses (p<0.005, k>20, uncorrected) associated with step time 
variability as per the parametric modulator analysis within the Parkinson’s disease 
group (n=23), between medication states (off/on). A= Whole brain BOLD responses 
within the Parkinson’s disease group off medication (PD OFF); B= Whole brain 
BOLD responses within the Parkinson’s disease group on medication (PD ON); C= 
Whole brain BOLD responses within the Parkinson’s disease group between 
medication states (PD OFF > PD ON); D=Parametric modulator data from one 
subjects in each group over the time course of the virtual reality task; E=Mean Beta 
values for the regions associated with the parametric modulator contrast OFF>ON, as 
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per figure C; F= Scatterplot and linear correlation between the loading of the 
parametric modulator (Beta values) onto the right lateral cerebellum cluster that was 
found to be significantly different on the contrast (OFF>ON) as per Figure 3C and the 
total functional connectivity within regions of the attention motor control network for 
Parkinson patients off medication (OFF) and on medication (ON). NOTE: 
ΔFSL=Absolute normalized and demeaned footstep latency per Repetition Time (3 
seconds) over the course of the virtual reality task walk condition; HC= Healthy 
Controls; CBM=Cerebellum, PMd=dorsal premotor cortex, PPC=Posterior Parietal 
Cortex; *indicates significant correlation. 
 
Figure 4: Results for the Condition (watch, walk) by Medication (off, on) Repeated 
Measures ANOVA on functional connectivity values within and between the three 
networks in Parkinson’s disease patients (n=23). Top left - Main effect of Medication 
(off, on); Bottom left - Condition x Medication Interaction effect; Each matrix 
provides summary statistics from the Repeated measures ANOVA analysis for 
within- and between network functional connectivity. P-values are embedded within 
each cell of the matrix. The colour scale represents F-values. Top right - Mean MTD 
values within the attention motor control network showing the main effect of 
medication; Bottom right - Mean MTD values within the striatum network showing 
the significant condition x medication interaction effect. NOTE: Auto=Motor 
Automaticity Network; Attn=Attention Motor Network; Stri=Striatum Network; PD 
off = Parkinson’s disease patients off dopaminergic replacement medication; PD on = 
Parkinson’s disease patients on dopaminergic replacement medication; *p<0.05, 
**p<0.05 FDR corrected.  
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Figure 5: Post-hoc correlation analysis between functional connectivity in limbic 
circuits and step time variability during the walk condition of the virtual reality task in 
Parkinson’s disease patients off their dopaminergic medication. A=Representation of 
the limbic intra-striatal and orbitofrontal-striatal functional connections; B=Scatter 
plots for the correlation analyses between functional connectivity in the intra-striatal 
limbic circuits and step time variability; C=Scatter plots for the correlation analyses 
between functional connectivity in the orbitofrontal-striatal limbic circuits and step 
time variability. NOTE: PD OFF=Parkinson’s disease patients off their dopaminergic 
replacement medication (n=23); Step time variability measured as the coefficient of 
variation in footstep latencies; DC=Dorsal Caudate; DCP=Dorsal Caudal Putamen; 
VSi=Inferior Ventral Striatum; OFC=Orbitofrontal Cortex; CV=Coefficient of 
Variation; *Indicates a significant p-value (p<0.05) that survived Bonferonni 
correction for multiple comparisons. 
 
 
Figure 6: Post-hoc correlation analysis between the amount of functional connectivity 
in the cognitive and motor cortico-striatal loops and intra-striatal limbic pathways in 
Parkinson’s disease patients on dopaminergic replacement medication (n=23). 
A=Representation of the cortico-striatal and intra-striatal limbic pathways used for the 
analysis; B=Scatter plots for the correlations between the amount of functional 
connectivity between the cognitive cortico-striatal loop and intra-striatal limbic 
pathways; C=Scatter plots for the correlations between the amount of functional 
connectivity between the motor cortico-striatal loop and intra-striatal limbic 
pathways. NOTE: PD ON = Parkinson’s disease patients on dopaminergic 
replacement medication; DC=Dorsal Caudate; DCP=Dorsal Caudal Putamen; 
VSi=Inferior Ventral Striatum; DLPFC=Dorsolateral Prefrontal Cortex; M1=Primary 
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motor cortex of the leg area; *Indicates a significant p-value (p<0.05) that survived 
Bonferonni correction for multiple comparisons. 
 
 
Highlights 
· Parkinson’s disease patients performed a virtual reality gait task during, fMRI 
· The role of dopamine on gait automaticity impairments was investigated 
· Limbic interference and poor striatal and cerebellar processing impair 
automaticity 
· Dopamine ameliorates gait automaticity impairments in Parkinson’s disease 
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